Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $549.9300 (-3.65%) ($548.2360 - $573.1600) on Thu. Sep. 10, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.3% (three month average) | RSI | 34 | Latest Price | $549.9300(-3.65%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -2.1% a day on average for past five trading days. | Weekly Trend | REGN declines -3.5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(54%) XLV(45%) SPLV(40%) IVW(38%) SPY(38%) | Factors Impacting REGN price | REGN will decline at least -1.15% in a week (0% probabilities). VIXM(-21%) IGOV(-9%) VXX(-7%) UUP(-7%) TBT(-6%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.15% (StdDev 2.3%) | Hourly BBV | -2.9 () | Intraday Trend | 0% | | | |
|
Resistance Level | $599.52 | 5 Day Moving Average | $568.12(-3.2%) | 10 Day Moving Average | $586.81(-6.28%) | 20 Day Moving Average | $599.52(-8.27%) | To recent high | -16.4% | To recent low | 0% | Market Cap | $58.308b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |